Abstract:Objective To construct prokaryotic expression systems of Staphylococcus enterotoxin A (SEA) gene and its mutants, and to determine the activity changes of recombinant expression products before and after mutation shown by cytotoxicity, promoting lymphocyte proliferation and inhibiting tumor cell growth. Methods sea gene with no signal peptide sequence of S. aureus strain ATCC13565 was amplified and then cloned by using high fidelity PCR and T-A cloning method. The site-specific mutants of sea gene using mutant primers as well as prokaryotic expression systems of the sea gene and its mutants were constructed. Ni-NTA affinity chromatography was performed to extract the expressed target recombinant proteins. The cytotoxicity to Vero cells of the recombi- nant proteins was measured using TCID_(50) titration method. MTT colorimetry was applied to examine the effects of the recombinant proteins at different dosages on promoting proliferation of mouse splenocytes and inhibiting growth of tumor cell lines KB and HL-60. Results The similarity of nucleotide sequence of the cloned sea gene was 100% as compared to the reported SEA sequences and the expected mutation of codons in each seven mutants at the scheduled positions was proved. All the recombiant protein expression outputs of sea gene and its mutants took approximate 52% of the total bacterial proteins. The TCID_(50) of rSEA's cytotoxicity to Vero cells was 4.1μg while the TCID_(50) values of the recombinant of sea gene mutants was 5.8-23.5μg, respectively. One and fiveμg/ml of rSEA and its five mutant proteins rSEA/H187A, rSEA/H225A, rSEA/D227 A, rSEA/H187A/D227A and rSEA/ H225A/D227A showed remarkable effects to promote proliferation of mouse splenocytes (P0.05). The activities of promoting mouse splenocyte proliferation of 10 and 20μg/ml rSEA and the five mutant proteins were similar to that of 100μg/ml PHA (P0.05). The supernatants or the mixture of supematant and splenocytes stimulated by 5-20μg/ml rSEA or each five mutant proteins efficiently inhibited the growth of KB and HL-60 cells (P0.05). Conclusion Since rSEA/H225A, rSEA/D227A and rSEA/H225A/D227A display lower cytotoxicity, stronger pro- moting of splenocyte proliferation and inhibiting tumor cell growth, the recombinant proteins of three mutants are potential candidates for leukogenic and anti-tumor SEA associated drugs.

Construction of Recombinant SEA Gene Eukaryotic Expression Vectors and Its Induction of Immune Response Against Murine Hepatoma

Construction of Site-Specific Mutants of Staphylococcus Enterotoxin A Gene and Biological Activities of Recombinant Expression Products

Construction and identification of prokaryotic expression system of staphylococcal enterotoxin A gene and expressed product

Superantigen-Sea Gene Modified Tumor Vaccine for Hepatocellular Carcinoma: an in Vitro Study

Construction of the Eukaryotic Coexpression Vector of SEA and Murine B7-1 and Its Expression in B16 Cell Line

In Vitro Biological Activities of Transmembrane Superantigen Staphylococcal Enterotoxin A Fusion Protein

Construction of Expression Vector of Superantigen Staphylococcal Enterotoxin A Gene

Antitumor effects of the fusion protein of transmembrane-staphylococcal enterotoxin A

[Construction of Hepatoma-Targeting Recombinant Co-Expression Adenovirus Vector of SEA and CD80 and Identification of Its Expression].

Preliminary study on distribution of hepatoma - targeting recombinant co - expression adenovirus vector of SEA and CD80 in mice

Recombinant adenovirus of SEA and CD80 genes driven by MMRE and mouse TERT promoter induce effective antitumor immune responses against different types of tumor cells in vitro and in vivo

A Novel Approach for Cancer Immunotherapy: Tumor Cells with Anchored Superantigen SEA Generate Effective Antitumor Immunity

Construction of Eukaryotic Expression System of Staphylococcal Enterotoxin A Gene and Identification of the Target Recombinant Protein

[The Construction and Expression of a Hepatocellular Carcinoma-Specific Superantigen SEA (D227A) Expression Vector].

Influence of Staphylococcal Enterotoxin A on Immunogenicity of Hepatocellular Carcinoma Cells

Construction of Superantigen SEA (D227A) and Its Immunological Identification

A non-viral gene therapy for melanoma by staphylococcal enterotoxin A

Preparation of murine B7.1-glycosylphosphatidylinositol and transmembrane-anchored staphylococcal enterotoxin. A dual-anchored tumor cell vaccine and its antitumor effect.

Superantigen SEA expressed by human hepatocellular carcinoma cells and presented by HLA-Ⅰ molecule.

Preliminary study on antitumor effect of C215gene transfected tumor vaccine and monoclonal antibody-superantigen fusion protein C 215Fab-SEA